Clinical Trial Update: Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pralatrexate to observation after CHOP-based chemotherapy in undiagnosed peripheral T-cell lymphoma patients; trial terminated with post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Pralatrexate (pralatrexate)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Peripheral T-cell Lymphoma | Phase 3 | Status: TERMINATED | Results posted: 2021-11-19